EN
Home/Guides/Getting a prescription
Guide 6 of 9 · Stage: Do it safely

Getting a prescription in Australia, and the medicines

First the prescription: who may prescribe, what the PBS covers, and the rules online doctors must follow. Then the medicines: what's approved, fakes, storing pens in the heat, and who pays.

GLP Guidebook teamUpdated 12 Oct 202615 min read47 sourcesWritten from published sources
The short answer

GLP-1 medicines are prescription-only in Australia. A GP can prescribe them after a real-time consultation, in person, by video or by phone; an online questionnaire alone isn't enough. The PBS subsidises them only for type 2 diabetes (Ozempic and Trulicity). For weight, you pay the full price on a private script, and your pharmacist can tell you what that will be. Talk to a doctor before starting, stopping or changing any medicine.

Key facts

Prescription
Always. All GLP-1 medicines are Schedule 4, prescription-only1
Who prescribes
Any registered prescriber, including your GP. We found no specialist-only rule1,2
Online
A real-time consultation is expected: in person, video or phone. A questionnaire or chat isn't enough3,4
PBS
Ozempic and Trulicity, for type 2 diabetes only. No GLP-1 is subsidised for weight5,6
Fakes
Counterfeit Ozempic pens, empty "GLP-1" drops and a fake "retatrutide" have all been found here7,8,9
Heat
Unused pens in the fridge. In use, most can be kept out of the fridge but not above 30°C, for a limited time10,11
On this page
  1. Who can prescribe a GLP-1 in Australia?
  2. What does the PBS cover?
  3. What rules do online doctors follow?
  4. Why can't anyone advertise these medicines?
  5. What should a proper consultation include?
  6. What are the red flags?
  7. Questions to ask a provider
  8. Which GLP-1 medicines are approved, and for what?
  9. Brand, generic or compounded?
  10. Pens, vials and tablets
  11. How do I spot a fake, store it in the heat, and get rid of needles?
  12. Who pays?
  13. Questions people ask
1See a registered doctor: your GP, or a doctor you can check on the Ahpra register
2A real-time consultation: your history, your weight and your other medicines
3A script for a medicine approved in Australia, on the PBS or private
4An Australian pharmacy, a checked pack, kept cool
5Follow-up while the dose goes up, and regular reviews

The order this guide follows. The prescriber comes first; the medicine comes second.

Part AGetting a prescription

Who can prescribe a GLP-1 in Australia?

Any registered prescriber, including your GP. We found no rule limiting them to specialists.1

All GLP-1 medicines are Schedule 4: prescription only. The TGA says they "can only be prescribed, dispensed or supplied by authorised health practitioners".1,2

On the PBS, Ozempic or Trulicity for type 2 diabetes need an authority approval for the first script, which your doctor gets by phone or online.5,12 On a private script, a doctor can prescribe Wegovy or Mounjaro for weight within their product information: a BMI of 30 or more, or 27 to 29.9 with a weight-related condition.10,11

Off-label prescribing means using a medicine for something it isn't approved for, like Ozempic for weight. In Australia a doctor may do this on their own judgement, but it's watched closely. In September 2026 Ahpra, which regulates health practitioners, said it may investigate doctors with high prescribing rates of these medicines even without a complaint.13 You can check any doctor, nurse or pharmacist on the Ahpra register.14

What does the PBS cover?

Type 2 diabetes only, for now. The PBS (Pharmaceutical Benefits Scheme) is the government's medicine subsidy, and it covers no GLP-1 medicine for weight.5,6

MedicineWhat we found
Ozempic, TrulicityOn the PBS for type 2 diabetes. An SGLT2 inhibitor must have not worked well enough, not suited you or not been tolerated, and your HbA1c must be above 7% on metformin, a sulfonylurea or insulin. The first script needs authority approval. Not subsidised alongside a DPP-4 or SGLT2 inhibitor, unless the SGLT2 inhibitor is for heart failure or kidney disease.5,12
WegovyNot on the PBS. In November 2025 the PBAC recommended it for adults with established heart disease and a BMI of 35 or more (32.5 for Asian, Aboriginal or Torres Strait Islander people). As of July 2026 the listing hadn't happened.6,15
MounjaroNot on the PBS. Recommended for type 2 diabetes in 2026, but its maker rejected the price terms and stopped the listing process. A listing for obesity now looks unlikely.16,17

On a PBS script you pay the standard co-payment, which is lower with a concession card, and a safety net caps your yearly total.18 GLP-1 medicines aren't on 60-day dispensing, so each script covers one month's supply at a time.5 The PBAC wants any wider access for weight to be "slow and managed".19 Guide 4 sets out the criteria in more detail.

What rules do online doctors follow?

The Medical Board of Australia doesn't support prescribing without a real-time consultation: in person, by video or by phone.3

  • A questionnaire isn't a consultation. The Board's guidelines say prescribing after you fill in a health questionnaire, when the doctor has never spoken with you, is not good practice.3
  • Neither is a chat. Ahpra says the Boards "do not consider an online chat to be a synchronous (in real time) consultation".4
  • Be wary of one-medicine services. Ahpra has raised concerns about services "designed solely to provide customers with access to a predetermined medicine", often with a linked pharmacy, where the prescriber may not be weighing up whether it's right for you.20
  • Ask for a real conversation and a full assessment. Ahpra's checklist for patients suggests checking you get both.20

Medicare and telehealth. Medicare rebates for telehealth GP visits usually need an existing relationship: a face-to-face visit with that doctor or practice in the last 12 months, or registration with the practice through MyMedicare.21 So many online weight services are private and charge their own fees.

Why can't anyone advertise these medicines?

It's illegal in Australia to advertise any prescription medicine to the public, including GLP-1 medicines. Promoting Ozempic for weight loss is illegal even to health professionals.22

The TGA's 2026 guidance says even indirect references can count, such as "weight-loss injections" or pictures of an injection pen. So can testimonials, eligibility quizzes that point to a medicine, and price lists outside the narrow rules for pharmacies.23,24 Since 2024 the TGA has fined telehealth businesses, pharmacies and individuals over this; one set of fines included allegations that businesses had claimed medicines were "TGA approved".25

What this means for you, and for us. An ad, testimonial or quiz pushing a "weight-loss jab" is a red flag in itself. It's also why this site names no providers, shows no prices, has no eligibility quiz and links to no sellers. We explain the rules and what to check; your doctor and pharmacist do the rest. Guide 7 explains the kinds of provider and what to ask.

What should a proper consultation include?

Questions about your health and medicines, your weight checked, and a plan for follow-up.

There's no single official checklist for a GLP-1 consultation. This list brings together what the Medical Board, the Australian algorithm and the product information say matters.3,10,26

  • Your history. Medullary thyroid cancer or MEN 2 (a rare inherited condition) in you or your family rules these medicines out under the US label.27 Past pancreatitis or gallstones matter too.27
  • Your other medicines. Insulin, or diabetes tablets like gliclazide, can cause low sugar (hypos) with a GLP-1. The dose of those may need to drop.27
  • Your weight and waist, checked. For Asian people, and as recommended for Aboriginal and Torres Strait Islander people, Australian guidance uses lower BMI cut-offs.26 Guide 1 explains the numbers.
  • Eyes. Diabetic eye disease can get worse, and the product information now warns about a rare sudden loss of vision (NAION).10
  • Pregnancy and contraception. Stop semaglutide at least 2 months, and tirzepatide at least 1 month, before a planned pregnancy. On Mounjaro, switch from the pill or add a condom for 4 weeks after starting and after each dose increase.10,11
  • Any surgery or procedure coming up. Australian anaesthetists advise most people to keep taking it, with clear fluids only for the 24 hours before.28
  • A follow-up plan. Who you contact about side effects, how your dose will go up, and when you'll review whether it's working.26

What are the red flags with a clinic, app or seller?

Walk away if nobody talks to you in real time, if the "medicine" comes from social media or overseas, or if it's sold as drops, patches or a "peptide".

  • Just a questionnaire or a chatThe Medical Board doesn't support prescribing without a real-time consultation.3,4
    Talks to you live, by video, phone or in person, and looks at your whole health.
  • One medicine for everyoneAhpra has warned about services built around a "predetermined medicine".20
    Discusses other options too, and is happy for you to say no.
  • Ads, testimonials or "TGA approved" claimsAdvertising prescription medicines to the public is illegal, and the TGA has fined businesses for it.22,25
    Offers a consultation first; the medicine is discussed only after it.
  • Drops, patches or "GLP-1 peptides"The TGA tested these products and found no GLP-1 medicine in them.8,29
    Supplies only a medicine approved in Australia, from an Australian pharmacy.
  • Compounded or "research" productsCompounded GLP-1s have been banned since October 2024. A fake "retatrutide" held about 8 times the approved semaglutide level.9,30
    A brand-name pen in its sealed pack, against your script.
  • Ordering from overseasCounterfeits can't be imported under the Personal Importation Scheme, and Border Force seizes products.2
    An Australian pharmacy you can visit or call.

Questions to ask a provider

Take these to the consultation. A good prescriber will be glad you asked.

  1. Who is the doctor, and can I check them on the Ahpra register?
  2. Will we talk in real time, and will you share notes with my usual GP?
  3. Is this medicine approved in Australia for my condition, and why this one?
  4. Would it be on the PBS for me, or a private script?
  5. What else should I try first or alongside it?
  6. Which side effects should make me contact you, and how do I reach you?
  7. How will my dose go up, and who decides each step?
  8. Does it affect my other medicines, my contraception or a pregnancy plan?
  9. What will the script cost at the full dose? (Your pharmacist can tell you.)
  10. What happens when I stop, and how long would I take it?
Part BThe medicines in Australia

Before you go further

  • Prescription only. Never start one without a prescriber.1
  • Know the risks first. Guide 5: Side effects and risks.
  • No promise of results. Weight loss varies a lot from person to person, and some people lose little.

We list brands and their approved uses as facts. We don't recommend any brand, company or seller, and we earn nothing from them.

Which GLP-1 medicines are approved in Australia, and for what?

Four medicines. Semaglutide (Wegovy) and tirzepatide (Mounjaro) are approved for weight; Ozempic, Rybelsus and Trulicity are for type 2 diabetes.10,11,31,32

The medicine is what works in your body; the brand is the name on the box. Paracetamol is a medicine; Panadol and Panamax are brands of it. One medicine can have several brands, each approved for different uses.

Diabetes approved for type 2 diabetes Weight approved for weight management

MedicineSemaglutide →
  • WegovyWeight10
    Weekly injection; Novo NordiskAlso approved to lower heart risk (December 2024), for teens 12 and over who weigh more than 60 kg (132 lb), and provisionally for a scarring fatty liver disease, MASH. Doses go up to 7.2 mg for some adults.10,33
  • OzempicDiabetes31
    Weekly injectionAlso for kidney disease in type 2 diabetes. Not approved for weight loss in Australia.31
  • RybelsusDiabetes34
    Daily tabletApproved in 2022. We couldn't confirm it is currently supplied here, and it isn't in the PBS diabetes tables.5,34
MedicineTirzepatide →
  • MounjaroDiabetesWeight11
    Weekly injection; Eli LillyAlso approved for moderate to severe sleep apnoea with obesity, and for type 2 diabetes from age 10 (50 kg or more). Zepbound, its US weight brand, isn't sold here.11,35
MedicineDulaglutide →
  • TrulicityDiabetes32
    Weekly injectionAlso approved to lower heart risk in type 2 diabetes.32
MedicineLiraglutide →
  • SaxendaWeight36
    Daily injectionNo longer sold in Australia after December 2025.36
  • Generic liraglutideWeight37,38
    Daily injection; several brandsCopies of Saxenda, first approved in March 2025.37,38

Medicine pages: Semaglutide Tirzepatide Liraglutide Dulaglutide

Not approved here (as of October 2026): we found no Australian approval for the higher-dose semaglutide tablet for weight, or for orforglipron. Retatrutide is still in trials.9

Brand, generic or compounded?

A generic is the same medicine made by another company once the patent ends. In Australia, only liraglutide has generics so far.37,38

We found no generic semaglutide or tirzepatide approved in Australia. Anything sold as one isn't an approved product.

Compounded versions are banned. Compounding means a pharmacy makes up its own version of a medicine. From 1 October 2024, pharmacists may not compound any GLP-1 medicine, in any form.30 Ahpra linked the ban to bulk-scale compounding by some telehealth businesses.20

Switching between brands is a prescriber's decision. Pens of different brands come in different strengths.

Pens, vials and tablets

Most GLP-1 medicines here come in pre-filled pens that measure the dose for you. Your pharmacist or GP can show you how to use yours.

  • Pens. A Wegovy FlexTouch or a Mounjaro KwikPen holds several weekly doses. A pen is for one person only, even with a new needle.10,11
  • Vials. Mounjaro has also come in single-dose vials, which were in short supply through 2025.11,39 Any vial or powder that didn't come from an Australian pharmacy against your script is a warning sign.7,30
  • Tablets. Rybelsus, for type 2 diabetes, is the only GLP-1 tablet approved here, and we couldn't confirm it is supplied.34
Too much, or severe pain? If you think you've injected too much, call the Poisons Information Centre on 13 11 26. If you have severe stomach pain that won't go away, or can't keep fluids down, call triple zero (000).40,41

How do I spot a fake, store it in the heat, and get rid of needles?

Fakes have been found in Australia. Only use a pack from an Australian pharmacy, against your script.7,8

The TGA has warned about counterfeit Ozempic pens (September 2024 and April 2025) and counterfeit semaglutide vials (May 2023).7 In 2026 it found "GLP-1" drops and patches with no GLP-1 in them, and a "retatrutide" product that contained about 8 times the approved level of semaglutide.8,9

Check the pack when you collect it

Something wrong? Don't use it. Keep the pen and packaging, tell the pharmacy, and report it to the TGA.42 Guide 5 explains how.

Keep it cool, especially in summer

The Wegovy product information says to protect pens from excessive heat.10 On a hot day, keep the pen out of direct sun and out of a parked car. Check your own Consumer Medicine Information leaflet.

Used needles and pens

Put used needles straight into an approved sharps container, or a strong puncture-proof container with a lid.44 When it's full, ask your pharmacy, GP or local council where to drop it off: rules differ between states and councils. In New South Wales, the needle clean-up hotline is 1800 633 353.44 The National Diabetes Services Scheme gives free pen needles to registered people who use insulin; we couldn't confirm whether that covers people on a GLP-1 alone.45

Who pays?

It depends on why it's prescribed. We don't show prices: pharmacies set their own, and your pharmacist can tell you what a script will cost before you fill it.24

SituationWho pays
Type 2 diabetes that meets the PBS criteriaThe PBS subsidises Ozempic or Trulicity. You pay the standard PBS co-payment, less with a concession card, and the safety net limits your yearly total.5,18
Weight managementYou pay the full price on a private script, every month you take it. No GLP-1 is on the PBS for weight.6
Private health insuranceSome extras policies pay part of a non-PBS script, only above the PBS co-payment and within yearly limits. Some insurers exclude weight-loss medicines.46,47 Ask your fund in writing.
The doctor's visitMedicare rebates GP visits, including telehealth with a GP you've seen in the last 12 months or are registered with through MyMedicare.21 Many online weight services are private.

Budget in years, not months: weight usually comes back after stopping, and the Australian algorithm says these medicines will usually be needed long term.26 Guide 9 covers stopping.

The risks, in brief

  • Feeling sick, vomiting, diarrhoea and constipation are common, mostly when the dose goes up.10
  • Inflamed pancreas (pancreatitis): severe stomach pain that won't settle.27
  • Gallbladder problems, including gallstones.27
  • Losing too much fluid from vomiting or diarrhoea can harm the kidneys.27
  • Not for people with medullary thyroid cancer or MEN 2 in themselves or their family (US label).27
  • Not in pregnancy. Stop semaglutide at least 2 months, and tirzepatide at least 1 month, before a planned pregnancy.10,11
Read Guide 5: Side effects and risks →

Questions people ask

Can my GP prescribe Mounjaro?

Yes. All GLP-1 medicines are prescription-only, and any registered prescriber, including a GP, can write a private script; we found no specialist-only rule.1 Mounjaro is approved for weight from a BMI of 30, or 27 with a weight-related condition, but it isn't on the PBS.11,17

Can I get Ozempic for weight loss in Australia?

Ozempic is approved for type 2 diabetes, not weight loss, and the PBS subsidises it only for type 2 diabetes that meets set criteria.5,31 Wegovy is the semaglutide brand approved for weight.10

Is Wegovy on the PBS?

Not as of July 2026. The PBAC recommended it in November 2025 for adults with established heart disease and a high BMI, but the listing hadn't happened.6,15

Is it safe to get a GLP-1 script online?

It can be, if a registered doctor consults you in real time by video or phone, and an Australian pharmacy supplies it. A questionnaire or chat alone isn't good practice.3,4 Never buy drops, patches or "peptides" online.8

Is compounded semaglutide legal in Australia?

No. Since 1 October 2024, pharmacists may not compound any GLP-1 medicine.30

Is Zepbound available in Australia?

No. In Australia, tirzepatide is sold as Mounjaro, approved for type 2 diabetes, weight management and sleep apnoea.11

How long can a pen be out of the fridge?

Unused pens go in the fridge. In use, a Mounjaro KwikPen can be kept unrefrigerated for up to 30 days, and a Wegovy FlexTouch for up to 42 days, but never above 30°C.10,11 Check your own leaflet.

Before you move on

  • A GP can prescribe these medicines; expect a real-time consultation, never just a form or chat.
  • The PBS covers Ozempic and Trulicity for type 2 diabetes only. For weight, it's a private script.
  • Ads, testimonials, drops, patches, compounded or "research" products are red flags.
  • Keep pens in the fridge until first use, and below 30°C after: watch hot cars in summer.
  • Ask your pharmacist what a script will cost, and budget in years, not months.
Side effects and risksShould I consider a GLP-1?Stopping and the long term
Was this guide easy to understand?

Sources

  1. Healthdirect Australia. Wegovy: medicine information ("Schedule 4: Prescription Only Medicine"). healthdirect.gov.au
  2. Therapeutic Goods Administration. How we regulate therapeutic peptide products (Personal Importation Scheme conditions; counterfeits cannot be imported). tga.gov.au
  3. Medical Board of Australia. Guidelines: Telehealth consultations with patients, in effect 1 September 2023 ("Prescribing … without a real-time direct consultation, whether in-person, via video or telephone, is not good practice and is not supported by the Board"). medicalboard.gov.au
  4. Ahpra. Information for practitioners who provide virtual care ("The Boards do not consider an online chat to be a synchronous (in real time) consultation"). Updated 7 October 2025. ahpra.gov.au
  5. Pharmaceutical Benefits Scheme. Type 2 diabetes mellitus pharmacotherapy diagram, at 1 December 2024 (GLP-1 RA subsidised after an SGLT2 inhibitor is contraindicated, not tolerated or not effective, with HbA1c above 7% on metformin, a sulfonylurea or insulin). pbs.gov.au
  6. Pharmaceutical Benefits Scheme. Medicine status: semaglutide (Wegovy), document 1460 ("Medicine listed on PBS: Has not yet occurred"), updated 23 July 2026. pbs.gov.au
  7. Therapeutic Goods Administration. Ozempic (semaglutide) safety collection, including counterfeit Ozempic pens detected (30 September 2024, 3 April 2025) and counterfeit semaglutide vials (25 May 2023). tga.gov.au
  8. Therapeutic Goods Administration. Counterfeit weight loss products claiming to contain GLP-1 (laboratory testing found "no GLP-1 or any GLP-1 analogues"). Safety advisory, 2 March 2026. tga.gov.au
  9. Therapeutic Goods Administration. TGA tests counterfeit retatrutide product following serious adverse event report (contained undeclared semaglutide, "approximately 8 times higher" than approved levels). Safety advisory, 14 September 2026. tga.gov.au
  10. Novo Nordisk. Wegovy (semaglutide) Australian Product Information, revised 22 June 2026 (sections 4.1, 4.2, 4.4, 4.6, 4.8, 6.4). medsinfo.com.au
  11. Eli Lilly. Mounjaro (tirzepatide) Australian Product Information, version A14.0, October 2026 (sections 4.1, 4.5, 4.6, 6.4). medsinfo.com.au
  12. Pharmaceutical Benefits Scheme. Semaglutide (Ozempic) item 12075M: type 2 diabetes, first prescription "Authority Required". pbs.gov.au
  13. newsGP (RACGP). Ahpra launches new guidance in peptide prescribing ("We may investigate the practice of practitioners with high rates of prescribing or compounding of any scheduled medicine, even if we have not received a complaint"). 16 September 2026. racgp.org.au
  14. Ahpra. Registers of practitioners ("When a health practitioner's name appears on the list, you know that they are allowed to practise"; includes medical practitioners, nurses and pharmacists, and any conditions on registration). Checked 12 October 2026. ahpra.gov.au
  15. newsGP (RACGP). Wegovy recommended for PBS listing (established cardiovascular disease; BMI 35 or more, or 32.5 or more for Asian, Aboriginal or Torres Strait Islander patients). 19 December 2025. racgp.org.au
  16. newsGP (RACGP). Mounjaro manufacturer rejects PBS recommendation ("price conditions proposed by the Australian Government are unrealistic and unviable"). 28 April 2026. racgp.org.au
  17. Pharmaceutical Benefits Scheme. Medicine status: tirzepatide (Mounjaro), document 1609 ("The pharmaceutical company has advised that it is not proceeding in the PBS listing process"). pbs.gov.au
  18. Pharmaceutical Benefits Scheme. What are the current patient fees and charges? (the co-payment set from 1 January 2026, lower with a concession card, and the safety net). pbs.gov.au
  19. Pharmaceutical Benefits Scheme. PBAC advice: equitable access to GLP-1 obesity treatments ("a slow and managed roll-out of access to PBS-subsidised GLP-1 treatments"). pbs.gov.au
  20. Ahpra and National Boards. Joint statement on prescribing and dispensing ("services designed solely to provide customers with access to a predetermined medicine"). 3 June 2024. ahpra.gov.au
  21. Department of Health, Disability and Ageing. MBS factsheet: Medical practitioners, non-referred MBS telehealth services (face-to-face service in the previous 12 months, or MyMedicare registration from 1 November 2025). Updated 23 October 2025. mbsonline.gov.au
  22. Therapeutic Goods Administration. Advertising Ozempic and GLP-1 receptor agonists is prohibited ("It is illegal to advertise Ozempic for weight loss, even to health professionals"). Updated 11 March 2025. tga.gov.au
  23. Therapeutic Goods Administration. Complying with the restrictions on advertising prescription medicines to the public. Guidance, 18 June 2026. tga.gov.au
  24. Therapeutic Goods Administration. Applying the Advertising Code rules: price information. Updated 21 July 2026. tga.gov.au
  25. Therapeutic Goods Administration. Media release on telehealth businesses fined for alleged unlawful advertising of weight-loss medicines (including alleged claims that medicines were "TGA approved"). Media release, 12 July 2024. tga.gov.au
  26. Markovic TP, Proietto J, Dixon JB et al. The Australian Obesity Management Algorithm. Australian Diabetes Society, with ANZOS, ANZMOSS and the RACGP, July 2024. diabetessociety.com.au
  27. Novo Nordisk. Wegovy (semaglutide) US prescribing information, revised June 2026: contraindications, warnings, overdose, patient counselling. Not the Australian label. PDF
  28. ANZCA, with the Australian Diabetes Society, GESA and NACOS. Clinical practice recommendations regarding patients taking GLP-1 receptor agonists ("continue these medications"; 24-hour clear-fluid diet, then the standard six-hour fast). anzca.edu.au
  29. Therapeutic Goods Administration. Imported unregistered GLP-1 weight loss products (oral "GLP-1 peptide" drops with fake endorsements). Safety advisory, 29 September 2025. tga.gov.au
  30. Therapeutic Goods Administration. Update: glucagon-like peptide-1 receptor agonists (GLP-1 RAs) pharmacy compounding changes (no compounding of any GLP-1 RA from 1 October 2024). Media release, 18 June 2024. tga.gov.au
  31. Novo Nordisk. Ozempic (semaglutide) Australian Product Information, revised 25 September 2026 (sections 4.1, 4.2, 4.6, 6.3). medsinfo.com.au
  32. Eli Lilly. Trulicity (dulaglutide) Australian Product Information, revised 28 May 2026. medsinfo.com.au
  33. newsGP (RACGP). Wegovy approved for cardiovascular disease in overweight and obesity (TGA registration 19 December 2024). 17 February 2025. racgp.org.au
  34. Therapeutic Goods Administration. Rybelsus (semaglutide) prescription medicine decision summary: decision 4 February 2022, registered 7 February 2022. tga.gov.au
  35. newsGP (RACGP). Mounjaro approved to treat sleep apnoea. 4 June 2025. racgp.org.au
  36. Novo Nordisk. Discontinuation of Saxenda: letter to health professionals ("Saxenda will not be available for purchase in Australia after December 2025"), May 2025. novonordisk.com.au
  37. Pearce IP. Approval alert: Sun Pharma achieves first generic liraglutide approval in Australia, 6 March 2025; and Cipla's generic liraglutide second to be approved, 12 March 2025. Law-firm reports. pearceip.law
  38. Pearce IP. Approval alert: Cipla's generic liraglutide second to be approved in Australia. 12 March 2025. Law-firm report. pearceip.law
  39. newsGP (RACGP). Mounjaro expanded to include weight management (vial shortage "expected to continue through August 2025"). 11 September 2024. racgp.org.au
  40. Healthdirect Australia. Poisoning (Poisons Information Centre, 13 11 26). healthdirect.gov.au
  41. Healthdirect Australia. How healthdirect can help you ("call triple zero (000) for an ambulance immediately"; helpline 1800 022 222). healthdirect.gov.au
  42. Therapeutic Goods Administration. Reporting adverse events: consumers (report online, or ask your doctor or pharmacist to report). Updated 2 September 2026. tga.gov.au
  43. Eli Lilly. Trulicity Australian Product Information, section 6.4 (may be kept unrefrigerated for up to 14 days at up to 30°C). Revised 28 May 2026. medsinfo.com.au
  44. NSW Health. Community sharps disposal ("store your used sharps in a puncture-proof container"; needle clean-up hotline 1800 633 353). health.nsw.gov.au
  45. National Diabetes Services Scheme (NDSS). Pen needles and syringes ("If you are registered with the NDSS and use insulin, you can access free pen needles and syringes"). ndss.com.au
  46. HIF. Can you claim for weight loss drugs on your extras cover? ("Benefits can only be paid on non-PBS prescription items"; "The cost of the item must exceed the current PBS co-payment"). 30 July 2026. Insurer article. hif.com.au
  47. The Nightly. Private health insurer HBF tightens belt on weight-loss drug coverage (Saxenda, Contrave, Duromine, Wegovy and compounded weight-loss medicines dropped from 9 July 2024). 1 May 2024. News report. thenightly.com.au

Last checked 12 Oct 2026 · PBS status re-checked monthly · Next full review due Jan 2027 · Report an error

How this guide was made. Written by the GLP Guidebook team from the sources above: TGA, PBS, Medical Board, Ahpra and Medicare documents, Australian product information and Australian clinical guidance. We don't sell medicines, name providers or show prices. It's general information, not medical advice. Talk to your GP or another qualified prescriber before starting, stopping or changing any medicine. In an emergency, call triple zero (000). For health advice any time, call healthdirect on 1800 022 222. Report suspected side effects to the TGA. How we write